2019
DOI: 10.1016/j.actatropica.2018.12.041
|View full text |Cite
|
Sign up to set email alerts
|

Evidence of multiple point mutations in Theileria annulata cytochrome b gene incriminated in buparvaquone treatment failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
46
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(50 citation statements)
references
References 29 publications
2
46
2
Order By: Relevance
“…On contrary to our findings, a recent study by Chatanga et al (2019) found that only 3 non-synonymous mutations on 50 isolates at codon 146 (50/50), 129 (18/50) and 227 (3/50), while no mutations were present in the Qo2 site in all studied sequences. The possible explanation is that the samples used in its study were collected from animals treated with buparvaquone regardless of whether or not these animals responded to the therapy.…”
Section: Resultscontrasting
confidence: 99%
“…On contrary to our findings, a recent study by Chatanga et al (2019) found that only 3 non-synonymous mutations on 50 isolates at codon 146 (50/50), 129 (18/50) and 227 (3/50), while no mutations were present in the Qo2 site in all studied sequences. The possible explanation is that the samples used in its study were collected from animals treated with buparvaquone regardless of whether or not these animals responded to the therapy.…”
Section: Resultscontrasting
confidence: 99%
“…From 1990s, several cases of treatment failure with buparvaquone were reported in Tunisia (M. Darghouth, unpublished data), leading then to suspect the emergence of T. annulata resistance stocks to buparvaquone. This phenomenon was confirmed later in vivo (Mhadhbi et al, 2010), and the resistance mechanism was associated with single point mutations affecting the cytochrome b gene (Sharifiyazdi, Namazi, Oryan, Shahriari, & Razavi, 2012;Mhadhbi, Chaouch, Ajroud, Darghouth, & BenAbderrazak, 2015;Chatanga et al, 2019). However, another study revealed that the mutation of the gene encoding the parasite enzyme PIN1 represents an additional resistance mechanism to buparvaquone, which acts in the absence of the mutation, by inhibiting the proliferation of the T. annulata host cell via blocking the PIN1 enzyme (Marsolier et al, 2015).…”
Section: Towards Improvement Of the Control Of Tropic Al Theilerios Ismentioning
confidence: 86%
“…Buparvaquone resistance has been reported with increasing frequency and now represents a serious challenge to efficient livestock production (Mhadhbi et al, 2010). Current understanding of the mechanisms and genetic basis of buparvaquone resistance in T. annulata is limited (Chatanga et al, 2019; Mhadhbi et al, 2015; Sharifiyazdi et al, 2012), with no functional link between mutations in the candidate cytochrome b locus and resistance phenotype having been demonstrated. Although previous studies have described multiple genotypes and high levels of genetic diversity (Al-Hamidhi et al, 2015; Weir et al, 2011), there is a lack of information on changes in response to drug selection pressure, fitness costs of mutations, and gene flow.…”
Section: Introductionmentioning
confidence: 99%
“…Buparvaquone resistance has been reported in several countries and now represents a serious challenge to efficient livestock production (Mhadhbi et al, 2010). Although mutations in the candidate cytochrome b locus linked to resistance phenotype have been demonstrated, a causal relationship has not been established (Chatanga et al, 2019; Mhadhbi et al, 2015; Sharifiyazdi et al, 2012). Previous studies have described multiple genotypes and high levels of genetic diversity in T. annulata (Al-Hamidhi et al, 2015; Weir et al, 2011), although there is a lack of information on the genotypic diversity of drug-resistant parasites and whether there are fitness costs associated with mutations of the cytochrome b locus.…”
Section: Introductionmentioning
confidence: 99%